Search research articles
Contact Us
Filters
Showing results (41-50 of 466) with videos related to
Page
of 47
Sort By:
Leukemia Research
|
August 28, 2009
MDM2 promotor polymorphism and disease characteristics in CLL
Thorsten Zenz, Axel Benner, Stephan Stilgenbauer
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 30, 2020
Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature
Igor Kos, Stephan Stilgenbauer, Moritz Bewarder
Cancer Treatment Reviews
|
January 13, 2017
Front-line treatment of CLL in the era of novel agents
Tadeusz Robak, Stephan Stilgenbauer, Alessandra Tedeschi
Current Drug Targets
|
November 1, 2006
Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia
Dirk Winkler, Hartmut Döhner, Stephan Stilgenbauer
Seminars in Oncology
|
April 18, 2006
Risk stratification in chronic lymphocytic leukemia
Till Seiler, Hartmut Döhner, Stephan Stilgenbauer
British Journal of Haematology
|
March 12, 2026
Short and complex-Telomeres and genomes in CLL
Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer
Cancers
|
January 8, 2023
To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL?
Karol D Urbanek, Stephan Stilgenbauer, Daniel Mertens
Clinical Advances in Hematology & Oncology : H&O
|
January 4, 2011
Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events
Asher Chanan-Khan, Thomas Kipps, Stephan Stilgenbauer
Blood Reviews
|
March 26, 2011
Importance of genetics in chronic lymphocytic leukemia
Thorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Leukemia & Lymphoma
|
May 3, 2008
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications
Thorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Page
of 47
Search research articles
Search
Showing results (41-50 of 466) with videos related to
Sort By:
Page
of 47
Leukemia Research
|
August 28, 2009
MDM2 promotor polymorphism and disease characteristics in CLL
Thorsten Zenz, Axel Benner, Stephan Stilgenbauer
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
April 30, 2020
Renal AA amyloidosis leading to early diagnosis and treatment of takayasu arteritis: a case report and review of the literature
Igor Kos, Stephan Stilgenbauer, Moritz Bewarder
Cancer Treatment Reviews
|
January 13, 2017
Front-line treatment of CLL in the era of novel agents
Tadeusz Robak, Stephan Stilgenbauer, Alessandra Tedeschi
Current Drug Targets
|
November 1, 2006
Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia
Dirk Winkler, Hartmut Döhner, Stephan Stilgenbauer
Seminars in Oncology
|
April 18, 2006
Risk stratification in chronic lymphocytic leukemia
Till Seiler, Hartmut Döhner, Stephan Stilgenbauer
British Journal of Haematology
|
March 12, 2026
Short and complex-Telomeres and genomes in CLL
Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer
Cancers
|
January 8, 2023
To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL?
Karol D Urbanek, Stephan Stilgenbauer, Daniel Mertens
Clinical Advances in Hematology & Oncology : H&O
|
January 4, 2011
Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events
Asher Chanan-Khan, Thomas Kipps, Stephan Stilgenbauer
Blood Reviews
|
March 26, 2011
Importance of genetics in chronic lymphocytic leukemia
Thorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Leukemia & Lymphoma
|
May 3, 2008
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications
Thorsten Zenz, Daniel Mertens, Hartmut Döhner, et al.
Page
of 47